The latest drugs in development that reduce intraocular pressure in ocular hypertension and glaucoma

V Jayanetti, S Sandhu, JA Lusthaus - Journal of Experimental …, 2020 - Taylor & Francis
… -lowering therapies and then outlines pipeline ocular hypotensive agents, their mechanisms
… new drug classes, such as tyrosine protein kinase activators. Most developing drugs are …

[HTML][HTML] Topical medication therapy for glaucoma and ocular hypertension

T Wang, L Cao, Q Jiang, T Zhang - Frontiers in Pharmacology, 2021 - frontiersin.org
… Comparing to eye drops containing preservatives, preserver free medicines can better
decrease the incidence of ocular side effects and increase ocular comfortable. So, it is necessary …

Pharmacological management of ocular hypertension: current approaches and future prospective

C Bucolo, S Salomone, F Drago, M Reibaldi… - Current opinion in …, 2013 - Elsevier
… endeavors facing the ocular pharmacology scientist. … ocular hypertension with a particular
attention to the novel molecules classified in two major classes: inflow and outflow drugs

Current situation and progress of drugs for reducing intraocular pressure

P Liu, F Wang, Y Song, M Wang… - … advances in chronic …, 2022 - journals.sagepub.com
… According to the latest clinical guidelines for glaucoma, the … drug that is primarily used
for the treatment of ocular … dextrose induced ocular hypertension in rats OHT, glaucoma …

Answers from the ocular hypertension treatment study

P Palmberg - Archives of ophthalmology, 2002 - jamanetwork.com
… risk for progression of ocular hypertension was estimated to … treatment of glaucoma and
ocular hypertension. In the high-… open-angle glaucoma to ocular hypertension. Furthermore, in …

Brimonidine in the treatment of glaucoma and ocular hypertension

LB Cantor - Therapeutics and clinical risk management, 2006 - Taylor & Francis
drugs are currently the only medical treatment approved for glaucoma management. The
classes of ocular hypotensive drugs … This latest study provides the strongest published results …

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open …

…, Ocular Hypertension Treatment Study … - Archives of …, 2002 - jamanetwork.com
Drugs were distributed to clinics from the study's central … of POAG among individuals with
ocular hypertension in population-… to a clinician caring for a patient with ocular hypertension. …

Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study

DR Anderson - JAMA ophthalmology, 2021 - jamanetwork.com
… years ago in the Ocular Hypertension Treatment Study (OHTS… started treatment when ocular
hypertension was discovered … Does this mean that patients with ocular hypertension might …

Ocular hypotensive drugs

AM Willis - Veterinary Clinics: Small Animal Practice, 2004 - vetsmall.theclinics.com
… differences in ocular anatomy and physiology can limit the usefulness of certain drugs in …
a given drug in a particular species or even in an individual animal. Extrapolation of topical …

The management of glaucoma and intraocular hypertension: current approaches and recent advances

RJ Noecker - Therapeutics and clinical risk management, 2006 - Taylor & Francis
… of glaucoma and ocular hypertension. When selecting an … , but also the ability of the drug to
allow patients to achieve target … The latest formulation of brimonidine is currently available as …